NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.20 +0.25 (+0.32%) GOLD FUTURES
2,312.60 +3.00 (+0.13%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,216.83 +1,098.18 (+2.38%)
Oscar Health, Inc. (OSCR)
After hours:
| Previous close | 17.36 |
| Open | 17.69 |
| Bid | 18.09 x 800 |
| Ask | 18.35 x 3000 |
| Day's range | 17.14 - 18.49 |
| 52-week range | 4.72 - 18.55 |
| Volume | |
| Avg. volume | 3,129,532 |
| Market cap | 4.287B |
| Beta (5Y monthly) | 1.78 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Oscar Health, Inc. to Host 2024 Investor Day
NEW YORK, April 10, 2024--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, will host its 2024 Investor Day on Friday, June 7, 2024 in New York City. Management will discuss the Company's corporate strategy, financial performance, and long-term financial targets.
- Business Wire
Oscar Health, Inc. 2024 First Quarter Conference Call
NEW YORK, April 02, 2024--Oscar Health, Inc. ("Oscar") (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024.
- Business Wire
Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability
NEW YORK, February 07, 2024--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2023.
